Skip to main content
. 2019 Feb 3;2019:5917269. doi: 10.1155/2019/5917269

Table 3.

Baseline information of patients in the 3 groups.

Indicators Control group
(n = 52)
Allopurinol group
(n = 55)
Chuanhutongfeng mixture group (n = 58) P-value
Age 49.90 ± 9.00 50.50 ± 8.90 51.10 ± 9.10 0.784
Gender (% of males) 50 (96.15) 53 (96.36) 55 (94.83) 0.908
BMI (kg/m2) 25.33 ± 1.12 25.46 ± 1.06 25.50 ± 1.26 0.726
Systolic pressure (mmHg) 133.00 ± 7.00 132.00 ± 8.00 134.00 ± 7.00 0.354
Diastolic pressure (mmHg) 76.00 ± 5.00 75.00 ± 7.00 75.00 ± 6.00 0.618
Disease duration (years) 9.90 ± 5.11 9.91 ± 5.42 9.87 ± 5.50 0.999
Tophus (n, %) 26 (50.00) 28 (50.91) 30 (51.72) 0.984
FBG (mmol/L) 5.12 ± 0.58 5.21 ± 0.46 5.17 ± 0.63 0.710
TC (mmol/L) 4.89 ±0.45 5.03 ± 0.46 5.10 ± 0.47 0.057
TG (mmol/L) 2.17 ± 0.85 2.21 ± 0.72 2.16 ± 0.81 0.940
ALT (U/L) 30.20 ± 9.50 29.50 ± 8.80 31.70 ± 8.40 0.406
AST (U/L) 25.10 ± 7.70 24.80 ± 7.40 27.90 ± 8.50 0.074
eGFR(ml/min/1.73m2) 110.10 ± 7.40 111.50 ± 7.50 110.40 ± 7.70 0.339
SUA (μmol/L) 532.00 ± 69.00 529.00 ± 72.00 530.00 ± 74.00 0.976
ESR (mm/h) 31.00 ± 14.20 33.90 ± 15.70 32.20 ± 16.30 0.622
CRP (mg/L) 21.30 ± 9.20 20.40 ± 10.80 22.00 ± 12.10 0.734
Pain score 3.54 ± 1.57 3.71 ±1.58 3.64 ±1.38 0.843
Swelling score 1.97 ± 0.89 1.97 ± 0.95 1.97 ± 0.88 1.000
Restricted movement score 1.98 ± 0.72 1.98 ± 0.89 1.99± 0.88 0.997
CCL2 (pg/mL) 538.00 ± 223.00 545.00 ± 175.00 572.00 ± 160.00 0.597
CXCL8 (pg/mL) 619.00 ± 199.00 643.00 ± 181.00 645.00 ± 218.00 0.757
miR-486-5p 2.51 ± 1.22 2.31 ± 1.19 2.24 ± 1.31 0.505
miR-339-5p 4.90 ± 1.98 4.93 ± 2.16 4.64 ± 2.18 0.725
miR-361-5p 3.27 ± 1.80 3.15 ± 1.77 2.98 ± 1.47 0.661

BMI: body mass index; FBG: Fasting blood-glucose; TC: Total cholesterol; TG: triglyceride; ALT: alanine aminotransferase; AST: aspartate aminotransferase; eGFR: estimate glomerular filtration rate; SUA: serum uric acid; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; CCL2: chemokine (C-C motif) ligand 2; CXCL8: chemokine (C-X-C motif) ligand 8.